Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer.

Date publication

janvier 2023

Journal

Lung cancer (Amsterdam, Netherlands)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel , Dr MARTIN Etienne

Tous les auteurs :
Scherpereel A, Martin E, Brouchet L, Corre R, Duruisseaux M, Falcoz PE, Giraud P, Le Péchoux C, Wislez M, Alifano M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36682142

Résumé

The optimal management of patients with non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer (NSCLC) remains controversial. In this modified Delphi study from France, we aimed to generate agreement through multidisciplinary decision-making on the clinical management of patients with non-bulky/non-infiltrative N2 NSCLC.

Mots clés

Delphi consensus, Multidisciplinary consensus, Multidisciplinary tumour board, N2 disease, Non-bulky/non-infiltrative, Non-small cell lung cancer

Référence

Lung Cancer. 2023 01 18;177:21-28